Back to Home
Free CE/CMEVideo

Emerging Therapeutic Advancements in Dry Eye Disease Management

Release Date

March 31, 2026

Expiration Date

April 1, 2027

Credits

1.0 CME, COPE

Specialties

Optometry, Ophthalmology

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in dry eye disease (DED). In this educational program, these experts use a case-based format to discuss the latest data regarding management of this disorder, share their perspectives and best practices, and forecast applications of key clinical challenges and questions regarding the diagnosis and treatment of DED and the updated report from the third Tear Film and Ocular Surface Society Dry Eye Workshop (TFOS DEWS III).

This educational activity is an archive of the live virtual symposium held on February 16, 2026.

Target Audience

This educational activity is directed toward ophthalmologists, optometrists, and other eyecare professionals involved in the management of patients with dry eye disease (DED).

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Summarize the clinically relevant updates on the diagnosis and management of DED in the 2025 TFOS DEWS III reports
  • Select appropriate diagnostic methods in the assessment of patients with DED to identify etiologic drivers
  • Evaluate the mechanisms, safety, efficacy, and ease of use of current and novel therapies that address DED subtypes and etiologic factors
  • Develop individualized treatment plans for optimal management of DED for cataract and refractive surgery patients
Emerging Therapeutic Advancements in Dry Eye Disease Management

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC designates this activity for a maximum of 1.0 COPE credit.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Harrow, Inc; and Sun Pharmaceutical.

Follow Us on Social Media!

Related Content

Course

Emerging Therapeutic Advancements in Dry Eye Disease Management

Create Account